T2 Biosystems CS (TTOO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 1,012 | 1,049 | 564 | 188 | 0 |
| Cost of Goods | 908 | 829 | N/A | 3 | N/A |
| Gross Profit | 104 | 220 | 564 | 185 | N/A |
| Operating Expenses | 12,555 | 12,214 | 11,088 | 10,339 | 8,957 |
| Operating Income | -11,543 | -11,165 | -10,524 | -10,151 | -8,838 |
| Interest Expense | 512 | 501 | 477 | 477 | 251 |
| Other Income | 23 | 22 | 6 | 9 | 13 |
| Pre-tax Income | -12,032 | -11,644 | -10,995 | -10,619 | -9,076 |
| Net Income Continuous | -12,032 | -11,644 | -10,995 | -10,619 | -9,076 |
| Net Income | $-12,032 | $-11,644 | $-10,995 | $-10,619 | $-9,076 |
| EPS Basic Total Ops | -2,850.00 | -2,850.00 | -2,700.00 | -2,650.00 | 45,800.00 |
| EPS Basic Continuous Ops | -2,824.28 | -2,863.61 | -2,713.34 | -2,644.04 | 34,845.47 |
| EPS Diluted Total Ops | -2,850.00 | -2,850.00 | -2,700.00 | -2,650.00 | 45,800.00 |
| EPS Diluted Continuous Ops | -2,824.28 | -2,863.61 | -2,713.34 | -2,644.04 | 34,845.47 |
| EBITDA(a) | $-11,057 | $-10,786 | $-10,177 | $-9,898 | $-8,725 |